Stage II Invasive Lobular Carcinoma: Alma's Patient Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage II
- Subtype
- Invasive Lobular Carcinoma
- Sex
- Female
- Treatment
- surgery, chemotherapy, radiation and hormone therapy
- Outcome
- Setback / Progression
Treatment course, step by step
- Persistent left-sided breast/armpit pain despite clear mammogram and 2 reassuring doctor visits
- breast specialist ultrasound found suspicious mass
- biopsy confirmed cancer
- lumpectomy found invasive lobular carcinoma measuring almost 2 inches / 5 cm
- chemotherapy and radiation recommended, followed by 10 years of tamoxifen
- local recurrence found 4.5 years after the initial diagnosis despite clear scans and repeated underarm pain.
What happened, in summary
Alma had always been vigilant about breast self-checks and annual mammograms because her mother had been treated for breast cancer. After moving from St. Louis to Australia with her husband and 2 sons, she began having recurring pain on her left side and under her arm. A mammogram looked normal, and 2 doctors reassured her, but the pain persisted. Alma found a breast specialist on her own. A quick ultrasound identified a suspicious mass, and a biopsy confirmed cancer 2 days later. During lumpectomy, the tumor that had been missed on at least 2 mammograms measured almost 2 inches, about 5 cm. The pathology report showed invasive lobular carcinoma, a subtype Alma had never heard of before. Information online was limited in 2017, and she felt she had to raise the lobular diagnosis herself during care. Her treatment plan included chemotherapy, radiation, and 10 years of tamoxifen. Four and a half years after the initial diagnosis, Alma found a local recurrence. Once again, scans had looked clear, but repeated pain under her arm told her something was wrong. Alma later connected with LBCA and began advocating for better awareness, imaging access, and research connections for people with ILC, especially in Australia.
Where this story comes from
This is a lay summary of an account first published by Lobular Breast Cancer Alliance. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer